• Digoxin, Free, Serum
  • Lipoprotein Associated Phospholipase A2 Activity
  • Estrone, Serum
  • Trazodone, Urine
  • Dopamine D1 receptor (DRD1) Antibody, IgG
  • Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis
  • Zinc, 24 Hour, Urine
  • p16 by Immunohistochemistry (CINtecĀ® and CINtecĀ® PLUS Cytology)
  • X and Y Aneuploidy Detection, FISH
  • SARS-CoV-2 (COVID-19) Coronavirus, Molecular
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
Medical Test

References
Access to MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection is restricted.
Loading...